SIGA Technologies Inc. (SIGA) Stock Price

SIGAStock

$3.17−62.04%52W

Market Cap$227.76M

P/E9.78x

PEG Ratio3.37

Div yield0.00%

Beta1.05

SIGA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-40.69%

Price vs S&P 500 (4W)1.64%

PEG Ratio3.37

VGM Score46.83

P/E Ratio (Annual)9.78x

Indicated Dividend Yield (Annual)0.00%

P/CF (Annual)5.24x

Book Value / Share (Quarterly)$2.30

P/TBV (Annual)20.08x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-5.14%

Cash Flow / Share (Quarterly)$-0.29

Payout Ratio (TTM)346.19%

Price vs S&P 500 (YTD)-60.04%

Gross Margin (TTM)54.35%

Net Profit Margin (TTM)-5.19%

EPS (TTM)$-0.04

10-Day Avg Trading Volume0.59M

EPS Excl Extra (TTM)$-0.04

Revenue Growth (5Y)-5.43%

EPS (Annual)$0.32

Dividend / Share (Annual)$0.60

ROI (Annual)11.71%

Gross Margin (Annual)68.59%

Net Profit Margin (5Y Avg)39.71%

Cash / Share (Quarterly)$1.64

P/E Basic Excl Extra (TTM)10.81x

Revenue Growth QoQ (YoY)-49.45%

EPS Growth (5Y)-14.51%

P/E Normalized (Annual)9.78x

ROA (Last FY)10.61%

Revenue Growth TTM (YoY)-70.13%

EBITD / Share (TTM)$-0.15

ROE (5Y Avg)26.70%

Operating Margin (TTM)-20.76%

Cash Flow / Share (Annual)$0.60

P/B Ratio1.38x

P/B Ratio (Quarterly)1.58x

Net Income / Employee (Annual)$475,100

EV / Revenue (TTM)2.05x

Net Interest Coverage (TTM)12.31x

ROA (TTM)-1.32%

EPS Growth QoQ (YoY)-64.93%

EV / EBITDA (TTM)5.19x

EPS Incl Extra (Annual)$0.32

Current Ratio (Annual)11.83x

Quick Ratio (Quarterly)15.90x

3-Month Avg Trading Volume0.69M

52-Week Price Return-62.04%

EV / Free Cash Flow (Annual)2.56x

P/E Incl Extra (TTM)10.81x

Revenue / Employee (TTM)$1,095,100

Tangible BV / Share (Quarterly)$0.15

P/S Ratio (Annual)2.41x

Asset Turnover (Annual)0.43x

52-Week High$8.55

Operating Margin (5Y Avg)48.09%

EPS Excl Extra (Annual)$0.32

CapEx CAGR (5Y)77.76%

Tangible BV CAGR (5Y)19.88%

26-Week Price Return-30.79%

Quick Ratio (Annual)8.79x

13-Week Price Return-7.85%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)21.72x

Enterprise Value$110.18M

Revenue / Share Growth (5Y)-3.52%

Asset Turnover (TTM)0.25x

Book Value / Share Growth (5Y)10.55%

Revenue / Employee (Annual)$1,930,100

Inventory Turnover (Annual)0.60x

Pretax Margin (Annual)32.12%

Cash / Share (Annual)$2.16

3-Month Return Std Dev46.60%

Gross Margin (5Y Avg)82.36%

Net Income / Employee (TTM)$-56,900

EBITDA CAGR (5Y)-21.23%

EBITDA Interim CAGR (5Y)155.15%

ROE (Last FY)11.71%

Net Interest Coverage (Annual)70.15x

EPS Basic Excl Extra (Annual)$0.32

P/FCF (TTM)15.01x

Receivables Turnover (TTM)7.86x

EV / Free Cash Flow (TTM)2.67x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.04

Receivables Turnover (Annual)7.74x

ROI (TTM)-1.55%

P/S Ratio (TTM)4.24x

Pretax Margin (5Y Avg)51.26%

Revenue / Share (Annual)$1.32

Tangible BV / Share (Annual)$0.15

Forward P/E4.61x

Free OCF CAGR (5Y)-9.62%

Price vs S&P 500 (52W)-77.57%

P/E Ratio (TTM)10.81x

EPS Growth TTM (YoY)-58.42%

Year-to-Date Return-48.12%

5-Day Price Return0.32%

EPS Normalized (Annual)$0.32

ROA (5Y Avg)22.27%

Net Profit Margin (Annual)24.61%

Month-to-Date Return-6.76%

Cash Flow / Share (TTM)$-0.06

EBITD / Share (Annual)$0.34

EPS Growth (3Y)-11.11%

Operating Margin (Annual)25.06%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)7.88x

ROI (5Y Avg)26.70%

P/E Excl Extra (TTM)10.81x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.04

P/TBV (Quarterly)20.08x

Payout Ratio (Annual)185.22%

P/B Ratio (Annual)2.20x

Dividend / Share (TTM)$0.61

Inventory Turnover (TTM)0.64x

Pretax Margin (TTM)-10.27%

Book Value / Share (Annual)$2.78

Price vs S&P 500 (13W)-10.53%

Net Margin Growth (5Y)-11.39%

Dividend Yield (TTM)19.12%

Beta1.05x

P/FCF (Annual)5.28x

Revenue / Share (TTM)$0.75

ROE (TTM)-1.55%

52-Week Low$2.83

vGradeB

gGradeF

mGradeC

vgmGradeC

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
SIGASIGA Technologies Inc.	B	F	C	4.2x	-70.1%	54.4%	-14.5%	$3.17
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About SIGA Technologies Inc.

SIGA Technologies is a commercial-stage pharmaceutical company focused on health security solutions. Its flagship product, TPOXX, is an oral antiviral treatment for human smallpox caused by the variola virus. The company derives its revenue primarily from the United States market.